Publication | Closed Access
LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
63
Citations
0
References
2020
Year
Advanced HeadRadiation MedicineRadiation TherapyMedicineHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!